WAST Cell
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for WAST Cell, covering 2026-01-09 to 2026-01-09. Get the full timeline:
Most recent: Clinical Trial Update: WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC [Phase 2]